Background: Depression during pregnancy is associated with a number of negative impacts on maternal and infant health, therefore good control of depression in pregnant women is crucial. There is a lack of population-level information about patterns of antidepressant use during pregnancy in New Zealand.
Aim: To describe antidepressant dispensing patterns before, during, and after pregnancy in New Zealand, 2005-2014.
Materials And Methods: Antidepressant dispensing records from 270 days prior to pregnancy through to 360 days after pregnancy end were linked with 805 990 pregnancies in the New Zealand Pregnancy Cohort. Proportions (and 95% confidence intervals) with at least one dispensing were calculated for the periods before, during, and after pregnancy and compared over time and by maternal characteristics.
Results: Dispensing during the first trimester was lower than in the pre-pregnancy and post-pregnancy periods, and dropped further in later trimesters. The proportion of pregnancies during which an antidepressant was dispensed rose from 3.1 to 4.9% over the study years. Around 80% of those with a dispensing received a selective serotonin reuptake inhibitor. Dispensing before, during, and after pregnancy varied by ethnicity, age, smoking status, and body mass index. Among women taking an antidepressant before pregnancy, younger women and those of Māori, Pacific, or Asian ethnicity were less likely to continue therapy during pregnancy.
Conclusions: This study has established a baseline for antidepressant use around pregnancy in New Zealand, documented increasing use over time, and demonstrated that known ethnic differences in antidepressant use are also evident in the pregnant population.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/ajo.13352 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Analysis of User-Generated Posts on Social Media of Adjuvant Analgesics: A Machine Learning Study.
Int J Med Sci
January 2025
Department of Medicine and Medical Specialities. University of Alcala, Alcala de Henares, 28801 Madrid, Spain.
Antiepileptics and antidepressants are frequently prescribed for chronic pain, but their efficacy and potential adverse effects raise concerns, including dependency issues. Increased prescriptions, sometimes fraudulent, prompted reclassification of antiepileptics in some countries. Our aim is to comprehend opinions, perceptions, beliefs, and attitudes towards co-analgesics from online discussions on X (formerly known as Twitter), offering insights closer to reality than conventional surveys.
View Article and Find Full Text PDFHealthcare costs associated with receipt of effective mental healthcare coverage in individuals with moderate or severe symptoms of anxiety and depression.
Int J Ment Health Syst
December 2024
Alberta's Tomorrow Project, Cancer Research & Analytics, Cancer Care Alberta, Alberta Health Services:, 1820 Richmond Road SW, Calgary, AB, T2T 5C7, Canada.
Background: Effective mental healthcare coverage (EMHC) is an important health system performance indicator of a population's mental healthcare needs. This study aims to assess the factors and healthcare costs associated with the receipt of EMHC for anxiety and depression.
Methods: This study draws on data from participants from Alberta's Tomorrow Project with moderate or severe symptoms of anxiety and depression during the first wave of the COVID-19 pandemic (2020) with available medico-administrative and complete data [n = 720].
Current Utilization of Bupropion Treatment in Children, Young Adults, and Adults in the United States.
J Child Adolesc Psychopharmacol
December 2024
New Jersey Poison Information and Education System, Department of Emergency Medicine, New Jersey Medical School Rutgers Biomedical and Health Sciences, Newark, New Jersey, USA.
While available for decades, the use of bupropion has increased in recent years. To provide an updated review on the use of bupropion, this article aimed to describe bupropion prescription details, potential indication, and treatment duration in children, young adults, and adults starting bupropion treatment. Individuals aged 6-64 newly initiating bupropion hydrochloride treatment were identified from commercial claims data (MarketScan, 1/1/2016-12/31/2022).
View Article and Find Full Text PDFCommunity pharmacist involvement in social prescribing for mental health: a qualitative study.
Prim Health Care Res Dev
December 2024
Department of Pharmacy and Pharmacology, University of Bath, Claverton Down, Bath and Northeast Somerset, UK.
Aim: We aimed to explore participant perspectives on social prescribing (SP) for mental health and well-being and the acceptability of community pharmacists (CP) as members of SP pathways that support people with mild to moderate depression and anxiety.
Background: SP aims to support people with poor health related to socio-demographic determinants. Positive effects of SP on self-belief, mood, well-being, and health are well documented, including a return to work for long-term unemployed.
Patterns of antidepressant use in people with low back pain: A retrospective study using workers' compensation data.
Eur J Pain
January 2025
Healthy Working Lives Research Group, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
Article Synopsis
- * The study analyzed data from LBP claims between 2010 and 2018, focusing on when and how often these medications were dispensed, as well as patterns of switching between different antidepressants.
- * Various factors influenced the dispensing of antidepressants, including demographic aspects like sex and age, prior use of other pain medications, and socioeconomic status, indicating a complex interplay between mental and physical health treatment strategies in this population.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!